No Data
No Data
Emergent BioSolutions Reinforces Its Commitment to Expanding Access to NARCAN Nasal Spray by Supporting Organizations With New Opioid Overdose Preparedness Programs
Emergent Biosolutions Directors Make Significant Stock Sales!
Insider Sale: Director at $EBS Sells 35,000 Shares
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
Emergent to Sell Baltimore-Bayview Facility for $36.5 Million
Express News | Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International